Flunixin Meglumine

Specifications

42461-84-7CAS Number

255-836-0EC Number

(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acidIUPAC Name

C21H28F3N3O7Chemical Formula

491.5 g/molMolecular Weight

FLUNIXIN MEGLUMINE; 42461-84-7; Banamine; Sch 14714 meglumine; Flumeglumine; Flunixin-S; Flunixin N-methylglucanine; Sch-14714 meglumine; Flunixin meglumine salt; 8Y3JK0JW3U; NSC-759583; CHEBI:76144; 2-((2-Methyl-3-(trifluoromethyl)-phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded; DTXCID9025584; Flunazine; Flunine; VetaMeg; Banamine Paste; Flunazine-S; Vetameg S; Banamine Granules; Flu-Nix; Flunixin Injection; Flunixin Injection-S; Banamine, Banamine-S; RefChem:57818; Flunixin Meglumine Solution; Flunixin Meglumine Injection; 255-836-0; DTXSID1045584; Flunixin meglumin; Flunixin (meglumine); MFCD01725419; 2-(2-Methyl-3-trifluoromethylanilino)nicotinic Acid N-Methyl-D-glucamine Salt; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)nicotinate; 1-Deoxy-1-(methylamino)-D-glucitol 2-(2-methyl-3-(perfluoromethyl)anilino)nicotinate; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid; Banamine (Veterinary); Flunixin Meglumine [USAN]; SMR000875279; C21H28F3N3O7; SR-05000001901; EINECS 255-836-0; UNII-8Y3JK0JW3U; Flunixin meglumine [USAN:USP]; Flunixin meglumine CRS; Flunixin meglumine (USP); Banamine [vetarynary] (TN); SCHEMBL43691; BSPBio_002558; 2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-Trifluoro-2,3-xylidino)nicotinic acid compound with 1-deoxy-1-(methylamino)-D-glucitol (1:1); MLS001333159; MLS002153985; SPECTRUM1505113; orb1309402; orb3139672; CHEMBL1733447; SCHEMBL29521359; SCHEMBL29608812; Flunixin (meglumine) (Standard); HY-B0386R; MSK7156; HMS2093I10; HMS2234K05; HMS3884J07; Pharmakon1600-01505113; FLUNIXIN MEGLUMINE [MART.]; FLUNIXIN MEGLUMINE [USP-RS]; HY-B0386; FLUNIXIN MEGLUMINE SALT [MI]; MSK7156-100A; NSC759583; s2108; Flunixin meglumine, >=98% (HPLC); AKOS015895954; AC-6012; CCG-213338; FF23334; FLUNIXIN MEGLUMINE [GREEN BOOK]; KS-5126; NSC 759583; NCGC00180889-01; 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid 1-Deoxy-1-(methylamino)-D-glucitol; D-Glucitol, 1-deoxy-1-(methylamino)-, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylate (salt); FLUNIXIN MEGLUMINE [USP MONOGRAPH]; SW196448-3; D04216; Flunixin meglumine 100 |Ig/mL in Acetonitrile; H10204; AB00920714_05; AB00920714_06; F805125; Flunixin meglumine 100 microg/mL in Acetonitrile; Flunixin meglumine for veterinary use [EP monograph]; SR-05000001901-1; SR-05000001901-3; Flunixin meglumine Solution in Acetonitrile, 100ug/mL; Q27145782; Flunixin meglumine, European Pharmacopoeia (EP) Reference Standard; Flunixin meglumine, United States Pharmacopeia (USP) Reference Standard; 2-(2-Methyl-3-trifluorome thylanilino)nicotinic acid N-methyl-D-glucamine salt; Flunixin Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol2-((2-methyl-3-(trifluoromethyl)phenyl)amino)nicotinate; 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinate; 2-(.ALPHA.(SUP 3),.ALPHA.(SUP 3),.ALPHA.(SUP 3)-TRIFLUORO-2,3-XYLIDINO)NICOTINIC ACID COMPOUND WITH 1-DEOXY-1-(METHYLAMINO)-D-GLUCITOL (1:1); 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid--1-deoxy-1-(methylamino)-D-glucitol (1/1)Synonyms